AdvancePCS

New Medicare reimbursement, if implemented as is, will disrupt the close-knit oncology marketplace, changing lucrative relationships between physicians and manufacturers.. By David Kempner and Tom Ove

As biotech products ripen, manufacturers ponder how best to get them to patients. Specialty pharmacy providers can help, but which is worth the money? By Wendy Diller These days, more and more biotech

As health plans for the first time get serious about managing specialty pharma spending, manufacturers should take heed because the impact on their revenues could be great. By Wendy Diller In the fall

After the roller coaster of the past several years, PBMs are poised for a comeback, with Medicare coverage and the Internet adding to the clout of a consolidated industry. by David Cassak In the early